Melanoma is a highly heterogeneous disease and is capable of adapting quickly to changing environmental conditions, through the selection of slow-cycling populations with increased intrinsic drug resistance.
The conference focuses on pathophysiology and prevention of Gram-negative bacteria. The goal is to bring together leading investigators in the field for in depth discussions on the current global state of infections that drive anti-microbial resistance (AMR).
